SONIA
SONIA: Phase III Trial Assessing the Optimal Therapeutic Position of CDK4/6 Inhibitors for Patients With HR+/HER2- Advanced Breast Cancer

Released: June 08, 2023

Activity

Progress
1
Course Completed